Molecular pharmacology of LR-B/081, a new non-peptide angiotensin AT1 receptor antagonist
- 18 July 1995
- journal article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 290 (2) , 151-156
- https://doi.org/10.1016/0922-4106(95)90028-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonistBritish Journal of Pharmacology, 1995
- BMS‐180560, an insurmountable inhibitor of angiotensin II‐stimulated responses: comparison with losartan and EXP3174British Journal of Pharmacology, 1994
- Cloning of cDNA and Analysis of the Gene for Mouse Angiotensin II Type 2 ReceptorBiochemical and Biophysical Research Communications, 1993
- Characterization of an angiotensin type-1 receptor partial cDNA from rat kidney: Evidence for a novel AT1B receptor subtypeBiochemical and Biophysical Research Communications, 1992
- Identification of two subtypes in the rat type I angiotensin II receptorFEBS Letters, 1992
- Two angiotensin II binding sites in rat brain revealed using [125I]Sar1, Ile8-angiotensin II and selective nonpeptide antagonistsBiochemical and Biophysical Research Communications, 1990
- Identification of angiotensin II receptor subtypesBiochemical and Biophysical Research Communications, 1989
- Analysis of radioligand binding experimentsJournal of Pharmacological Methods, 1985
- Desensitization, two-state receptors and pharmacological parametersJournal of Theoretical Biology, 1983
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976